A ß1-ADR agonist prodrug compound, which is hydrolysable in vivo to release a ß1-ADR agonist compound, and which prodrug compound contains a group which imparts greater lipophilicity and CNS bioavailability to the prodrug compound relative to the ß1-ADR agonist compound.
展开▼